Company Profile
ImmuCell Stock Price, News & Catalysts
- Ticker:
- ICCC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
10.06 USD (-0.30%)
Close
Last updated: August 21, 2026
88.6M USD
Market cap
Why the stock is moving
As of Aug 21, 2026, ICCC closed down 0.30% at $10.06. No new same-company headline was identified in the current news window.
Company overview
Animal Health Biologics Company
ImmuCell develops biologic products intended to improve calf health and productivity. The company primarily serves dairy and livestock markets, with an emphasis on preventing early-life diseases such as neonatal calf diarrhea.
First Defense Franchise
The First Defense product line orally delivers antibodies derived from colostrum to provide immediate immune protection against major viral and bacterial causes of calf scours. Dual-Force and Tri-Shield are the franchise’s key growth products.
Commercial Execution
Growth depends on product availability, U.S. market demand, expansion of the commercial team, and distributor inventory cycles. The release did not identify a specific future clinical or regulatory milestone.
Future catalysts
- ImmuCell’s catalysts are animal-health product demand, manufacturing execution, and steady recurring revenue in veterinary biologics. The company moves on operating consistency rather than binary headlines.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ImmuCell (ICCC)?
ImmuCell (ICCC) most recently closed at 10.06 USD, a -0.30% move versus the previous session.
What is the market cap of ImmuCell (ICCC)?
ImmuCell currently has a market capitalization of 88.6M USD on BioPharmSignal.
What does ImmuCell do?
Animal Health Biologics Company ImmuCell develops biologic products intended to improve calf health and productivity. The company primarily serves dairy and livestock markets, with an emphasis on preventing early-life diseases such as neonatal calf diarrhea. First Defense Franchise The First Defense product line orally delivers antibodies derived from...
On which exchange is ICCC stock listed?
ImmuCell (ICCC) is associated with NASDAQ, United States, Biopharma.
What is Animal?
ImmuCell’s catalysts are animal-health product demand, manufacturing execution, and steady recurring revenue in veterinary biologics.
Which conditions is ImmuCell targeting with Animal?
ImmuCell’s catalysts are animal-health product demand, manufacturing execution, and steady recurring revenue in veterinary biologics.
How does ImmuCell describe recent progress with Animal?
ImmuCell’s catalysts are animal-health product demand, manufacturing execution, and steady recurring revenue in veterinary biologics.
What is Health?
Animal Health Biologics Company ImmuCell develops biologic products intended to improve calf health and productivity.